Discusses a study which compared patients receiving a T cell-depleted nonmyeloablative allogeneic stem cell transplant (SCT) with patients receiving a T cell-depleted myeloablative allogeneic SCT with delayed T cell addback over a 21-month period ending in September 1999. Treatments received by patients at risk for cytomegalovirus (CMV); Cases of CMV disease.